MODERN APPROACHES TO THERAPY OF UROGENITAL DISORDERS IN POST-MENOPAUSAL FEMALES
Abstract
Pathogenesis of isolated urogenital disorders in post-menopausal females is often rooted in reduced production of female sex hormones. As a rule, such disorders are not related to infectious diseases. Therefore, the main objective of therapy of postmenopausal urogenital disorders is to supplement the deficiency of female sex hormones. Topical administration of therapeutic doses of estriol as a cream or Ovestin suppositoria, is recognized as one of the safest methods of treatment. Upon completion of the treatment course, which duration is 3 weeks, a switching to maintenance therapy is indicated.
About the Authors
T. S. Perepanova
Federal State Facility Scientific research institute of urology of Ministry of Public Health and Social Development of Russia
Russian Federation
Russian Federation
P. L. Khazan
Federal State Facility Scientific research institute of urology of Ministry of Public Health and Social Development of Russia
Russian Federation
Russian Federation
References
1. Berging EW. Oestriol receptor interactions: their biological importance and therapeutic implications. Acta Endocrinol.1980; 233-9-16
2. Bachmann GA. The clinical platform for the 17beta-estradiol vaginal releasing ring. Am J Obstet Gynecol 1998; 178: S257-60.
3. Cardozo L, Lose G, Mc Clish D.,Versi E. A systematic review of the effects of estrogens for symptoms suggestive of overactive bladder. Acta Obstet Gynecol Scand 2004; 83:892-897
4. Raz R, Cologner R, Rohana Y,et al. Effectiveness of Estriol-Containing Vaginal Pessaries and Nitrofurantoin Macrocrystal Therapy in the Prevention of Recurrent Urinary Tract Infection in Postmenopausal Women. Clinical Infectious Diseases 2003, 36; 1362-8.
5. Lang WR. Vaginal acidity and pH: review. Obstet Gynecol Surv 1955; 10:546-60)
6. Raz R, Stamm WE. A controlled trial intravaginal estriol in postmenopausal women with recurrent urinary tract infection. N Engl J Med 1993; 329: 753-6.
7. Stamey T.A. Timothy M, Millar M, Mihara G. Recurrent urinary tract infections in adult women: the role of introinal enterobacteria. Calif Med 1971; 115:1-19
8. Chan RC, Reid G, Irvin RT, Bruce AW, Costerton JW. Competitive exclusion of uropathogens from human uroepithelial cells by Lactobacillus whole cells and cell wall fragments. Infect Immun 1985; 47:84-9.
9. Schaffer J, Fantl JA. Urogenital effects of the menopause. Baillie`res Clin Obstet Gynaecol 1996; 10: 401-17
10. Pandit L, Ouslander JG. Postmenopausal vaginal atrophy and atrophic vaginitis. Am J Med Sci 1997; 314: 228-31
11. Brown JS, GradyD, Ouslander JG,Herzog AR, VarnerRE, Posner SF. Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart Estrogen/Progestin Replacement Study (HERS) Resesrch Group. Obstet Gynecol 1999; 94: 66-70
12. Thomas TM, Plymat KR, Blannin J. Prevalence of urinary incontinence. BMJ 1980; 281: 1243-5.
13. Versi E, Cardozo LD. Estrogens and lower urinary tract function. In: Studd JWW, Whitehead MI, eds. The Menopause. Oxford: Blackwell Science, 1988: 76-84
14. Балан В.Е. Принципы заместительной гормонотерапии урогенитальных расстройств. Consilium Medicum. 2003; №7(5)
15. Балан В.Е. Урогенитальные расстройства в климактерии (клиника, диагностика, заместительная гормонотерапия). Дисс. д-ра мед. наук. М., 1998.
16. Балан В.Е., Сметник В.П. Урогенитальные расстройства в климактерии. Москва. 1998.
17. Baker V. Alternatives to oral oestrogen replacement: transdermal patches, percutaneous gels, vaginal creams and rings, implants, other methods of delivery. Obstet Gynecol Clin North Am 1994; 21: 271-97
18. Privette M, Cade R, Peterson J, Mars D. Prevention of recurrent urinary tract infections in postmenopausal women. Nephron 1988; 50:24-7
19. Инструкция по применению препарата Овестин
20. Богданова Е.А. Применение Овестина в практике гинеколога детей и подростков. Журнал Акушерства и Женских Болезней. 1998; 3(4): 74-75.
21. Mattsson La, Cullberg G.Vaginal absorption of 2 estriol preparations: a comparative study in postmenopausal women. Acta Obstet Gynecol Scand 1983; 62:393-6.
22. Callahan SM, Creed KE The effects of oestrogens on spontaneous activity and responses to phenylephril of mammailian urethra. J.Physiol, 1985,v. 358:35-46
23. Дьяков В.В., Годунов Б.Н., Гвоздев М.Ю. «Опыт длительного применения препарата «Овестин» у женщин, страдающих расстройствами мочеиспускания в постменопаузальном периоде//Урология, 2003, №1, с.43 -45
24. Тевлин К.П., Дьяков В.В., Пушкарь Д.Ю. Применение эстрогенов в комплексном лечении гиперактивного мочевого пузыря. Эффективная терапия в урологии. 2006; 1: 32-35
25. Пушкарь Д.Ю. Тазовые расстройства у женщин. МЕДпресс-информ. 2006; 254 стр
26. Trevoux R, van der Velden WH, Popovic D. Ovestin vaginal cream and suppositories for the treatment of menopausal vaginal atrophy. Reproduction 1982; 6:101-6.
27. Branderg A, Mellstrom D, Samsioe G. Low dose oral estriol treatment in elderly women with urogenital infections. Acta Obstet Gynecol Scand 1987; (suppl 140):33-8.
28. Серов В.Н. Терапия урогенитальных расстройств, обусловленных дефицитом эстрогенов. Акушерство, гинекология и репродукция. 2010; 1: 21-35
29. Новикова В.А., Федорович О.К., Атанесян Э.Г. Комплексная терапия атрофии урогенитального тракта у женщин пременопаузального периода с преждевременной недостаточностью функции яичников. Оржин. 2008; 7: 14-16
30. Chan RC, Reid G, Irvin RT, Bruce AW, Costerton JW. Competitive exclusion of uropathogens from human uroepithelial cells by Lactobacillus whole cells and cell wall fragments. Infect Immun 1985; 47:84-9
31. Batra SC, Iosif CS. Female urethra: a target for estrogen action. J Urol 1983; 129: 418-20
32. Privette M, Cade R, Peterson J, Mars D. Prevention of recurrent urinary tract infections in postmenopausal women. Nephron 1988; 50:24-7
33. Ледина А.В., Куликов А.Ю. Комплексное лечение и профилактика эстрогензависимых урогенитальных расстройств: клинические аспекты и фармакоэкономический анализ. Фармакоэкономика. 2009; 1: 13-18
34. Овсянникова Т.В., Макаров И.О., Боровкова Е.И., Куликов И.А. Местная терапия урогенитальных нарушений в пери-и постменопаузе. Акушерство, гинекология и репродукция. 2010; 3: 25-28
35. Orlander JD, Jick SS, Dean AD Urinary tract infections and estrogen use in older women. J Am Geriatr Soc 1992;40:817-20.
For citation:
Perepanova T.S., Khazan P.L. MODERN APPROACHES TO THERAPY OF UROGENITAL DISORDERS IN POST-MENOPAUSAL FEMALES. Obstetrics, Gynecology and Reproduction. 2011;5(1):10-13. (In Russ.)
Views: 211
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
